Purchase Order 75N93019P00699
Award Date 6/26/19
Potential Completion Date 7/9/19
Potential Value $100K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Newark, DE, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The National Institute of Allergy and Infectious Diseases awarded a $149,959.70 firm fixed-price purchase order to Geneuniversal Inc. on September 8, 2021, for gene synthesis, site-directed mutagenesis, PCR cloning, and plasmid preparation services. The contract, with an ultimate completion date of September 7, 2022, was issued to administratively de-obligate unexpended and expiring fiscal year 2021 funding in accordance with 31 U.S.C. Section 1552(a) in preparation for the September 30, 2026...
- This is a firm fixed price purchase order awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to Geneuniversal Inc., a for-profit biotechnology company, for gene synthesis services. The contract has a potential value of $148,279.20 and does not have a set-aside designation. The work will be performed out of Newark, Delaware and is likely to support NIH's infectious disease research efforts....
- This is a $200,219.00 firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) to Geneuniversal Inc., a for-profit biotechnology services provider based in Newark, Delaware. The contract is for DNA services including antibody gene synthesis, subcloning, and plasmid preparation to support the Vaccine Research Center's (VRC) efforts to develop vaccines against HIV/AIDS. This is a follow-on requirement to...
- This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to Geneimmune Biotechnology Corp, a small, Asian-Pacific American-owned biotechnology company based in Rockville, Maryland. The contract, valued at $98,958.95, is for the provision of various research and development services related to genetics, immunology, virology, and infectious diseases, including...
- This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the U.S. Department of Health and Human Services, to Geneimmune Biotechnology Corp, a for-profit Asian-Pacific American-owned biotechnology company based in Rockville, Maryland. The contract, valued at $98,347.40, is for DNA services including subcloning, mutagenesis, gene synthesis, and plasmid production to support NIAID's Vaccine Research Center's...
- This is a firm fixed-price purchase order contract awarded to Geneimmune Biotechnology Corp., a biotechnology company based in Rockville, Maryland. The $50,955 contract is for subcloning, mutagenesis, and DNA preparation test services, and was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the Department of Health and Human Services' National Institutes of Health. The contract has an ultimate completion date of January 19, 2015 and was awarded on...
- This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services, to Genscript USA Inc., a biotechnology company based in Piscataway, New Jersey. The $21,095.60 contract is for the provision of custom gene synthesis services to support NIAID's biomedical research and public health initiatives. Genscript USA Inc. is an experienced federal contractor, having received numerous...
- This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Genscript USA Inc., a biotechnology company based in Piscataway, New Jersey. The $4,833.25 contract is for custom gene synthesis services to support NIAID's biomedical research and public health initiatives. While the award does not have a set-aside designation, Genscript has previously received some small business...
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $249,243.54 firm fixed price purchase order to Genscript USA Inc. on August 27, 2023, for gene production and protein expression services. The contract, which was completed on August 26, 2024, encompasses gene synthesis, cloning, plasmid preparation, protein expression, and purification services to support NIAID's research initiatives. This was a sole source negotiated contract with no set-aside designation, awarded...
- The Department of Health and Human Services' National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded a $20,000 firm fixed price purchase order to Genscript USA Inc. to provide custom gene synthesis services. The contract will support NIH's research efforts at its Bethesda, Maryland campus through December 31, 2023. Genscript will deliver custom gene synthesis products to NIH researchers as part of the Institute's work to advance understanding of diseases...